Lead extraction outcomes in patients with congenital heart disease

Erin A. Fender, Ammar M. Killu, Bryan C. Cannon, Paul A. Friedman, Christopher J. Mcleod, David O. Hodge, Craig S. Broberg, Charles A. Henrikson, Yong Mei Cha

    Research output: Contribution to journalArticle

    • 2 Citations

    Abstract

    Aims: Patients with congenital heart disease (CHD) are at increased risk for intracardiac device malfunction and infection that may necessitate extraction; however, the risk of extraction is poorly understood. This study addresses the safety of extraction in patients with structural heart disease and previous cardiac surgery. Methods and results: This retrospective study included 40 CHD and 80 matched control patients, who underwent transvenous lead extractions between 2001 and 2014. Only leads >12 months were included. There were 77 leads in CHD patients and 146 in controls. The mean age was 38 ± 16 years in CHD patients. Ninety per cent of CHD patients had ≥1 cardiac surgeries when compared with 21% of controls (P < 0.001). The number of abandoned leads was significantly different (17 vs. 3, P < 0.001). Lead age was similar with an average duration of 83 ± 87 months in CHD patients and 62 ± 65 months in controls (P = 0.24). There was no significant difference in extraction techniques. Manual traction was successful in 40% of CHD patients and 47% of controls, and advanced techniques were used in 60 and 53% of CHD patients and controls, respectively. Complete extraction was achieved in 94% of the patients in both groups. There was no significant difference in complications. Conclusion: Lead extraction can be safely performed in patients with CHD. Despite anatomic abnormalities and longer implantation times, the difficulty of lead extraction in patients with CHD is comparable with controls.

    LanguageEnglish (US)
    Pages441-446
    Number of pages6
    JournalEuropace
    Volume19
    Issue number3
    DOIs
    StatePublished - 2017

    Fingerprint

    Heart Diseases
    Thoracic Surgery
    Lead
    Traction
    Retrospective Studies
    Safety
    Equipment and Supplies
    Infection

    Keywords

    • Cardiac implantable electronic device
    • Congenital heart disease
    • Laser lead extraction
    • Lead extraction

    ASJC Scopus subject areas

    • Cardiology and Cardiovascular Medicine
    • Physiology (medical)

    Cite this

    Fender, E. A., Killu, A. M., Cannon, B. C., Friedman, P. A., Mcleod, C. J., Hodge, D. O., ... Cha, Y. M. (2017). Lead extraction outcomes in patients with congenital heart disease. Europace, 19(3), 441-446. DOI: 10.1093/europace/euw049

    Lead extraction outcomes in patients with congenital heart disease. / Fender, Erin A.; Killu, Ammar M.; Cannon, Bryan C.; Friedman, Paul A.; Mcleod, Christopher J.; Hodge, David O.; Broberg, Craig S.; Henrikson, Charles A.; Cha, Yong Mei.

    In: Europace, Vol. 19, No. 3, 2017, p. 441-446.

    Research output: Contribution to journalArticle

    Fender, EA, Killu, AM, Cannon, BC, Friedman, PA, Mcleod, CJ, Hodge, DO, Broberg, CS, Henrikson, CA & Cha, YM 2017, 'Lead extraction outcomes in patients with congenital heart disease' Europace, vol. 19, no. 3, pp. 441-446. DOI: 10.1093/europace/euw049
    Fender EA, Killu AM, Cannon BC, Friedman PA, Mcleod CJ, Hodge DO et al. Lead extraction outcomes in patients with congenital heart disease. Europace. 2017;19(3):441-446. Available from, DOI: 10.1093/europace/euw049
    Fender, Erin A. ; Killu, Ammar M. ; Cannon, Bryan C. ; Friedman, Paul A. ; Mcleod, Christopher J. ; Hodge, David O. ; Broberg, Craig S. ; Henrikson, Charles A. ; Cha, Yong Mei. / Lead extraction outcomes in patients with congenital heart disease. In: Europace. 2017 ; Vol. 19, No. 3. pp. 441-446
    @article{341c6830de7247729eaa4556193bb124,
    title = "Lead extraction outcomes in patients with congenital heart disease",
    abstract = "Aims: Patients with congenital heart disease (CHD) are at increased risk for intracardiac device malfunction and infection that may necessitate extraction; however, the risk of extraction is poorly understood. This study addresses the safety of extraction in patients with structural heart disease and previous cardiac surgery. Methods and results: This retrospective study included 40 CHD and 80 matched control patients, who underwent transvenous lead extractions between 2001 and 2014. Only leads >12 months were included. There were 77 leads in CHD patients and 146 in controls. The mean age was 38 ± 16 years in CHD patients. Ninety per cent of CHD patients had ≥1 cardiac surgeries when compared with 21{\%} of controls (P < 0.001). The number of abandoned leads was significantly different (17 vs. 3, P < 0.001). Lead age was similar with an average duration of 83 ± 87 months in CHD patients and 62 ± 65 months in controls (P = 0.24). There was no significant difference in extraction techniques. Manual traction was successful in 40{\%} of CHD patients and 47{\%} of controls, and advanced techniques were used in 60 and 53{\%} of CHD patients and controls, respectively. Complete extraction was achieved in 94{\%} of the patients in both groups. There was no significant difference in complications. Conclusion: Lead extraction can be safely performed in patients with CHD. Despite anatomic abnormalities and longer implantation times, the difficulty of lead extraction in patients with CHD is comparable with controls.",
    keywords = "Cardiac implantable electronic device, Congenital heart disease, Laser lead extraction, Lead extraction",
    author = "Fender, {Erin A.} and Killu, {Ammar M.} and Cannon, {Bryan C.} and Friedman, {Paul A.} and Mcleod, {Christopher J.} and Hodge, {David O.} and Broberg, {Craig S.} and Henrikson, {Charles A.} and Cha, {Yong Mei}",
    year = "2017",
    doi = "10.1093/europace/euw049",
    language = "English (US)",
    volume = "19",
    pages = "441--446",
    journal = "Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology",
    issn = "1099-5129",
    publisher = "Oxford University Press",
    number = "3",

    }

    TY - JOUR

    T1 - Lead extraction outcomes in patients with congenital heart disease

    AU - Fender,Erin A.

    AU - Killu,Ammar M.

    AU - Cannon,Bryan C.

    AU - Friedman,Paul A.

    AU - Mcleod,Christopher J.

    AU - Hodge,David O.

    AU - Broberg,Craig S.

    AU - Henrikson,Charles A.

    AU - Cha,Yong Mei

    PY - 2017

    Y1 - 2017

    N2 - Aims: Patients with congenital heart disease (CHD) are at increased risk for intracardiac device malfunction and infection that may necessitate extraction; however, the risk of extraction is poorly understood. This study addresses the safety of extraction in patients with structural heart disease and previous cardiac surgery. Methods and results: This retrospective study included 40 CHD and 80 matched control patients, who underwent transvenous lead extractions between 2001 and 2014. Only leads >12 months were included. There were 77 leads in CHD patients and 146 in controls. The mean age was 38 ± 16 years in CHD patients. Ninety per cent of CHD patients had ≥1 cardiac surgeries when compared with 21% of controls (P < 0.001). The number of abandoned leads was significantly different (17 vs. 3, P < 0.001). Lead age was similar with an average duration of 83 ± 87 months in CHD patients and 62 ± 65 months in controls (P = 0.24). There was no significant difference in extraction techniques. Manual traction was successful in 40% of CHD patients and 47% of controls, and advanced techniques were used in 60 and 53% of CHD patients and controls, respectively. Complete extraction was achieved in 94% of the patients in both groups. There was no significant difference in complications. Conclusion: Lead extraction can be safely performed in patients with CHD. Despite anatomic abnormalities and longer implantation times, the difficulty of lead extraction in patients with CHD is comparable with controls.

    AB - Aims: Patients with congenital heart disease (CHD) are at increased risk for intracardiac device malfunction and infection that may necessitate extraction; however, the risk of extraction is poorly understood. This study addresses the safety of extraction in patients with structural heart disease and previous cardiac surgery. Methods and results: This retrospective study included 40 CHD and 80 matched control patients, who underwent transvenous lead extractions between 2001 and 2014. Only leads >12 months were included. There were 77 leads in CHD patients and 146 in controls. The mean age was 38 ± 16 years in CHD patients. Ninety per cent of CHD patients had ≥1 cardiac surgeries when compared with 21% of controls (P < 0.001). The number of abandoned leads was significantly different (17 vs. 3, P < 0.001). Lead age was similar with an average duration of 83 ± 87 months in CHD patients and 62 ± 65 months in controls (P = 0.24). There was no significant difference in extraction techniques. Manual traction was successful in 40% of CHD patients and 47% of controls, and advanced techniques were used in 60 and 53% of CHD patients and controls, respectively. Complete extraction was achieved in 94% of the patients in both groups. There was no significant difference in complications. Conclusion: Lead extraction can be safely performed in patients with CHD. Despite anatomic abnormalities and longer implantation times, the difficulty of lead extraction in patients with CHD is comparable with controls.

    KW - Cardiac implantable electronic device

    KW - Congenital heart disease

    KW - Laser lead extraction

    KW - Lead extraction

    UR - http://www.scopus.com/inward/record.url?scp=85019748231&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=85019748231&partnerID=8YFLogxK

    U2 - 10.1093/europace/euw049

    DO - 10.1093/europace/euw049

    M3 - Article

    VL - 19

    SP - 441

    EP - 446

    JO - Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

    T2 - Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

    JF - Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology

    SN - 1099-5129

    IS - 3

    ER -